SEASONAL CHOLESTEROL CYCLES - THE LIPID-RESEARCH-CLINICS CORONARY PRIMARY PREVENTION TRIAL PLACEBO GROUP

被引：130

作者：

GORDON, DJ

TROST, DC

HYDE, J

WHALEY, FS

HANNAN, PJ

JACOBS, DR

EKELUND, LG

机构：

[1] NHLBI,DIV HEART & VASC DIS,LIPID METAB ATHEROGENESIS BRANCH,BETHESDA,MD 20892

[2] ER SQUIBB & SONS INC,PRINCETON,NJ 08540

[3] GEORGE WASHINGTON UNIV,DEPT PATHOL,WASHINGTON,DC 20052

[4] UNIV N CAROLINA,DEPT BIOSTAT,CTR COLLABORAT STUDIES COORDINATING,CHAPEL HILL,NC 27514

[5] UNIV MINNESOTA,SCH PUBL HLTH,DIV EPIDEMIOL,MINNEAPOLIS,MN 55455

来源：

CIRCULATION | 1987年 / 76卷 / 06期

关键词：

D O I：

10.1161/01.CIR.76.6.1224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1224 / 1231

页数：8

共 50 条

[41] REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND CORONARY HEART-DISEASE EVENTS IN THE DIET PLUS PLACEBO GROUP IN THE CORONARY PRIMARY PREVENTION TRIAL
GLUECK, CJ
ARTERIOSCLEROSIS, 1984, 4 (05): : A543 - A543
[42] DIETARY CORRELATES OF CHANGES IN TOTAL AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL IN 3806 HYPERCHOLESTEROLEMIC MEN OF THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL (LRC-CPPT)
GLUECK, CJ
CLINICAL RESEARCH, 1986, 34 (02): : A636 - A636
[43] EPIDEMIOLOGY OF PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS - THE LIPID-RESEARCH-CLINICS PROGRAM PREVALENCE STUDY - INTRODUCTION
TYROLER, HA
CIRCULATION, 1980, 62 (05) : 1 - 3
[44] CORONARY HEART-DISEASE MORBIDITY AND MORTALITY IN HYPERCHOLESTEROLEMIC MEN PREDICTED FROM AN EXERCISE TEST - THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL
EKELUND, LG
SUCHINDRAN, CM
MCMAHON, RP
HEISS, G
LEON, AS
ROMHILT, DW
RUBENSTEIN, CL
PROBSTFIELD, JL
RUWITCH, JF
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (03) : 556 - 563
[45] Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial
Wanis, Kerollos Nashat
Madenci, Arin L.
Hernan, Miguel A.
Murray, Eleanor J.
CLINICAL TRIALS, 2020, 17 (05) : 570 - 575
[46] ELEVATED LIPOPROTEIN(A) LEVELS PREDICT CHD INCIDENCE IN THE PROSPECTIVE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL (LRC-CPPT)
SCHAEFER, EJ
JENNER, JL
ORDOVAS, JM
OGRADY, HK
DAVIS, CE
LIPPEL, K
CIRCULATION, 1992, 86 (04) : 812 - 812
[47] Polyunsaturated fatty acid (PUFA) intake in the development of cancer in participants in the lipid research clinics coronary primary prevention trial (LRC-CPPT).
Fisher, J
Ryu, SY
Snook, JT
FASEB JOURNAL, 1999, 13 (05): : A933 - A933
[48] RECRUITMENT FOR CLINICAL-TRIALS THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL EXPERIENCE - ITS IMPLICATIONS FOR FUTURE TRIALS - ORGANIZATION OF THE MONOGRAPH - FOREWORD
AGRAS, WS
BRADFORD, RH
CIRCULATION, 1982, 66 (06) : 1 - 1
[49] SENSITIVITY OF EXERCISE ELECTROCARDIOGRAPHY FOR ACUTE CARDIAC EVENTS DURING MODERATE AND STRENUOUS PHYSICAL-ACTIVITY - THE LIPID RESEARCH CLINICS CORONARY-PRIMARY-PREVENTION-TRIAL
SISCOVICK, DS
EKELUND, LG
JOHNSON, JL
TRUONG, Y
ADLER, A
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (02) : 325 - 330
[50] Treatment with cholestyramine in type 2A hyperlipidemics improves renal function: Results of the lipid research clinics coronary primary prevention trial (LRC-CPPT).
Hogan, SL
Colindres, RE
Tyroler, HA
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0712 - A0712

← 1 2 3 4 5 →